Jointown Pharmaceutical Group Co Ltd (600998.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Distributors · China · ISIN CNE100000W45

Price
4.89 CNY
Market cap
24.66 bn CNY
P/E (2025)
–
P/S (2025)
0.15
Dividend yield
4.09 %
Net margin
1.40 %
Return on equity (ROE)
6.12 %
Return on assets (ROA)
1.94 %

Jointown Pharmaceutical Group Co Ltd financials

Fiscal year20242025
Revenue151.81 bn CNY161.39 bn CNY
Gross profit11.74 bn CNY12.55 bn CNY
Operating income3.64 bn CNY4.04 bn CNY
EBIT3.92 bn CNY4.30 bn CNY
Net income2.51 bn CNY2.25 bn CNY

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Jointown Pharmaceutical Group Co Ltd

Jointown Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the digital pharmaceutical distribution and supply chain business in China. It operates through Distribution, Industrial, Retail, Medical and Health, and Other divisions. The company offers distribution, warehousing, medical and pharmaceutical logistics, and other services to pharmaceutical manufacturers; medicines and health products; medical, health, and technology value-added services; and digital logistics technology and supply chain solutions. It is also involved in the operation and franchising of retail pharmacy networks; general agency brand promotion business; pharmaceutical OEM business; and wholesale of medical devices. Jointown Pharmaceutical Group Co., Ltd was founded in 1999 and is headquartered in Wuhan, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.